The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Over the last few decades, we have seen incredible innovation in different types of therapeutic modalities. Cell and Gene therapies encompass many diverse approaches. Added to that are Live Biological Products (Microbiome) and increasingly complex combination approaches. The challenges facing biopharmaceutical manufacturing groups is how to translate this landscape into processes and supply chains that can support product registration and commercial supply.
Speaker(s):
Jim
Faulkner,
PhD,
Venture Partner,
Apple Tree Partners
You must be logged in and own this session in order to
post comments.